vyne stock forecast zacks

During the last trading day the stock fluctuated 288. VYNE stock price quote with breaking news financials statistics charts and more.

Vyne Vyne Therapeutics Full Company Report Zacks Com

VYNE Complete VYNE Therapeutics Inc.

. 17 2022 at 1200 pm. Stock news by MarketWatch. Available in swell forecast locations only.

The Zynerba Pharmaceuticals stock price fell by -0446 on the last day Friday 21st Oct 2022 from 0673 to 0670. View real-time stock prices and stock quotes for a full financial overview. Get a real-time VYNE Therapeutics Inc.

Useful for highlighting potentially dangerous conditions -- or legendary ones depending on your sport. The 3 analysts offering 12-month price forecasts for Vyne Therapeutics Inc have a median target of 400 with a high estimate of 500 and a low estimate of 150. The forecasts range from a low of 150 to a high.

Based on short-term price targets offered by four analysts the average price target for VYNE Therapeutics Inc. Get the latest VYNE Therapeutics VYNE detailed stock quotes stock data Real-Time ECN charts stats and more. According to the issued ratings of 13 analysts in the last year the consensus rating for NIO stock is Moderate Buy based on the current 1 hold rating and 12 buy ratings for NIO.

VYNE Therapeutics to Report Third Quarter 2021. Stock screener for investors and traders financial visualizations. Stock Price Forecast.

Plan you week with the help of our 10-day weather forecasts and weekend weather predictions for Frontier Park New York. According to 12 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 1816. Find the most current and reliable 36 hour weather forecasts storm alerts reports and information for Medford NY US with The Weather Network.

Swell height is higher than your limit. View VYNE Therapeutics VYNE investment stock information. Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning.

Why Vyne Therapeutics Stock Is Crashing Today The Motley Fool